Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7981 AL 7995

Decoding neuroinflammation in Alzheimer's disease: a multi-omics and AI-driven perspective for precision medicine

Lin S, Zhan Y, Wang R, Pei J.

Front Immunol. 2025 Jun 18;16:1616899. doi: 10.3389/fimmu.2025.1616899. eCollection 2025.

Pathogenesis and therapeutic applications of microglia receptors in Alzheimer's disease

Fu J, Wang R, He J, Liu X, Wang X, Yao J, Liu Y, Ran C, Ye Q, He Y.

Front Immunol. 2025 Feb 14;16:1508023. doi: 10.3389/fimmu.2025.1508023. eCollection 2025.

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives

Iwatsubo T, Sperling RA, Algeciras-Schimnich A, Arai H, Barron AM, Benzinger TLS, Carrillo MC, Chen C, Choi SH, Fontana IC, Graff-Radford J, Grill JD, Heidebrink J, Hu CJ, Ihara R, Ikeuchi T, Iwata A, Ip FCF, Fitri FI, Jack CR Jr, Jeong JH, Jia J, Kandiah N, Kim S, Kowa H, La Joie R, Niimi Y, Noritake R, Okonkwo OC, Palmqvist S, Rafii MS, Raman R, Shen Y, Simuni T, Snyder HM, Sriwannopas O, Stoeckel LE, van der Flier WM, Wang H, Wilcock DM, Zetterberg H, Zhou J, Mahinrad S, Sexton CE.

Alzheimers Dement. 2025 Aug;21(8):e70536. doi: 10.1002/alz.70536.

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease

Garbarino VR, Palavicini JP, Melendez J, Barthelemy NR, He Y, Kautz TF, Lopez-Cruzan M, Mathews JJ, Xu P, Zhang B, Saliba A, Ragi N, Sharma K, Mason D, Johnson S, Hendrix S, Craft S, Petersen RC, Espindola-Netto JM, Xue A, Tchkonia T, Kirkland JL, Salardini A, Musi N, Bateman RJ, Gonzales MM, Orr ME.

Neurotherapeutics. 2025 Jul;22(4):e00591. doi: 10.1016/j.neurot.2025.e00591. Epub 2025 Apr 23.

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications

Akash A, Ahamed M, Porel P, Aran KR.

Brain Res. 2025 Nov 15;1867:149949. doi: 10.1016/j.brainres.2025.149949. Epub 2025 Sep 19.

Comprehending Alzheimer's Disease: Molecular Mechanisms and Treatment Strategies

Rathee S, Pandey V, Soni S, Sen D, Jain SK.

Curr Alzheimer Res. 2025;22(6):414-441. doi: 10.2174/0115672050368798250626075628.

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease

Qiu Y, Jacobs DM, Messer K, Salmon DP, Wellington CL, Stukas S, Revta C, Brewer JB, Léger GC, Askew B, Donahue L, Kaplita S, Coric V, Qureshi IA, Feldman HH; Alzheimer’s Disease Cooperative Study T2 Protect AD Study Group.

Alzheimers Res Ther. 2025 May 2;17(1):97. doi: 10.1186/s13195-025-01745-3.

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Ahmadi S, Khaledi S, Ahmadi K, Hassanzadeh K.

CNS Neurosci Ther. 2025 Dec;31(12):e70688. doi: 10.1002/cns.70688.

Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

McCullough A, Chen CD, Gordon BA, Joseph-Mathurin N, Jack CR Jr, Koeppe R, Hornbeck R, Koudelis D, McKay NS, Hobbs DA, Flores S, Keefe SJ, Aggarwal NT, Allegri RF, Berman SB, Bird T, Black SE, Brooks WS, Chhatwal JP, Day GS, Farlow MR, Fox NC, Gauthier S, Honig LS, Hsiung GY, Jucker M, Levin J, Masellis M, Masters C, Mendez PC, Ringman JM, Snider BJ, Salloway S, Schofield PR, Shimada H, Suzuki K, van Dyck CH, Klein G, Clifford DB, Cruchaga C, Hassenstab J, Li Y, McDade E, Mills S, Morris JC, Perrin RJ, Supnet-Bell C, Wang G, Xiong C, Bateman RJ, Benzinger TLS; DIAN‐TU Study Team.

Alzheimers Dement. 2025 Jul;21(7):e70347. doi: 10.1002/alz.70347.

Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study

Chan D, de Weck G, Jackson BL, Suk HJ, Milman NP, Kitchener E, Avalos VSF, Quay MJ, Aoki K, Ruiz E, Becker A, Zheng M, Philips R, Firenze R, Geigenmüller U, Hammerschlag B, Arnold S, Kivisäkk P, Brickhouse M, Touroutoglou A, Brown EN, Boyden ES, Dickerson BC, Klerman EB, Tsai LH.

Alzheimers Dement. 2025 Oct;21(10):e70792. doi: 10.1002/alz.70792.

Key biomarkers in Alzheimer's disease: Insights for diagnosis and treatment strategies

Jamal R, Shaikh MA, Taleuzzaman M, Haque Z, Albratty M, Alam MS, Makeen HA, Zoghebi K, Saleh SF.

J Alzheimers Dis. 2025 Jun;105(3):679-696. doi: 10.1177/13872877251330500. Epub 2025 Apr 21.

Gut Fungi in Alzheimer's Disease: Mechanisms, Biomarkers and Therapeutic Potential

Liu Z, Chen Z, Zhang X, Ge Y, Yuan D, Zhai H.

Aging Dis. 2025 May 6;17(3):1484-1499. doi: 10.14336/AD.2024.1310.

Advances in Diagnostics and Treatments for Alzheimer's Disease

Sunderland A, Thatcher AL, Rackley EV, Kuruvilla T.

Br J Hosp Med (Lond). 2025 Dec 25;86(12):1-19. doi: 10.12968/hmed.2025.0492. Epub 2025 Dec 19.

TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy

Yuan S, Fuchs NS, Abdel-Rahman SA, Kaur B, Gabr MT.

Trends Pharmacol Sci. 2025 Aug;46(8):738-751. doi: 10.1016/j.tips.2025.06.010. Epub 2025 Jul 18.

Translating Alzheimer's Disease Mechanisms into Therapeutic Opportunities

Li J, Wang L, Zhang X, Shi J, Zhu Y, Wang H, Zhu X, Zhu Q, Luo JL.

Biomolecules. 2025 Sep 8;15(9):1290. doi: 10.3390/biom15091290.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias